Literature DB >> 2935625

Effect of antihypertensive treatment on the left ventricular isomyosin profile in one-clip, two kidney hypertensive rats.

J C Dussaule, J B Michel, C Auzan, K Schwartz, P Corvol, J Menard.   

Abstract

In order to investigate the cardiac effects of antihypertensive therapies in one-clip two-kidney hypertension in rats, we compared the consequences on myosin isoenzyme profile and on left ventricular hypertrophy of two treatments: one was a new converting enzyme inhibitor (S9490), the second a more standard tripletherapy associating clonidine, dihydralazine and furosemide. The two treatments were initiated 4 weeks after clipping and administered during 5 weeks. During the treatment period average systolic blood pressure was 215 +/- 32 mmHg in the hypertensive untreated group (HC2, n = 12) and 144 +/- 13 mm Hg in the CEI group (HT1, n = 13), which is not significantly different from the value found in the sham-operated group (139 +/- 4 mm Hg, C2, n = 13). Blood pressure was lowered only to 173 +/- 18 mm Hg in the group treated with tripletherapy (HT2, n = 12). The left ventricular weight decreased significantly in the CEI-treated group toward values similar to those of the sham-operated animals (2.2 +/- 0.13 mg/g vs. 1.9 +/- 10 mg/g, respectively NS), whereas it did not change in the tripletherapy group when compared to the untreated hypertensive animals despite the fall in blood pressure. In the hypertensive untreated rats the percentage of V1 isoenzyme of cardiac myosin was lower than in the sham-operated group (42.8 +/- 9.0% vs. 57.5 +/- 7.6% P less than .001). In parallel the V3 form of cardiac myosin increased (24.1 +/- 7.4% vs. 15.7 +/- 4.3%, P less than .001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2935625

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  A novel vascular clip design for the reliable induction of 2-kidney, 1-clip hypertension in the rat.

Authors:  Stephen P Chelko; Chad W Schmiedt; Tristan H Lewis; Stephen J Lewis; Tom P Robertson
Journal:  J Appl Physiol (1985)       Date:  2011-11-10

Review 2.  Role of ACE inhibitors in hypertension with left ventricular hypertrophy.

Authors:  A M Richards; M G Nicholls; I G Crozier
Journal:  Br Heart J       Date:  1994-09

Review 3.  Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  P A Todd; A Fitton
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

4.  Characterization of cardiac angiotensin converting enzyme (ACE) and in vivo inhibition following oral quinapril to rats.

Authors:  B Fabris; H Yamada; R Cubela; B Jackson; F A Mendelsohn; C I Johnston
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

5.  Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease.

Authors:  H Moreno; K Metze; A C Bento; E Antunes; R Zatz; G de Nucci
Journal:  Basic Res Cardiol       Date:  1996 May-Jun       Impact factor: 17.165

6.  Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase.

Authors:  J F Arnal; L Warin; J B Michel
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

Review 7.  Blockade of the renin-angiotensin system in hypertensive patients with atherosclerotic renal artery stenosis.

Authors:  Faical Jarraya; Menno Pruijm; Gregoire Wuerzner; Michel Burnier
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

8.  Establishment and evaluation of a reversible two-kidney, one-clip renovascular hypertensive rat model.

Authors:  Li-Qiang Li; Jian Zhang; Rong Wang; Jian-Xin Li; Yong-Quan Gu
Journal:  Exp Ther Med       Date:  2017-04-26       Impact factor: 2.447

9.  With a new clip technique surgically inducing varicocele in Sprague-Dawley rats.

Authors:  Wen-Bin Guo; Cheng Yang; Jun Bian; Hui Xia; Jian-Kun Yang; Qi-Zhao Zhou; Ming-Kun Chen; Kang-Yi Xue; Wan-Song Zhang; Peng Wang; Xin Li; Cun-Dong Liu
Journal:  BMC Urol       Date:  2018-06-07       Impact factor: 2.264

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.